Search research articles
Contact Us
Filters
Showing results (11-20 of 100) with videos related to
Page
of 10
Sort By:
Bulletin Du Cancer
|
March 12, 2015
[Should knowledge of BRCA1 status impact the choice of chemotherapy in metastatic breast cancer: a review]
Océane Clergue, Natalie Jones, Nicolas Sévenet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2011
Quality of randomized controlled trials reporting in the treatment of sarcomas
Maud Toulmonde, Carine Bellera, Simone Mathoulin-Pelissier, et al.
Cancer
|
April 24, 2007
Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis
Marc Debled, Gaëtan MacGrogan, Véronique Brouste, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2007
Expression profiling in breast carcinoma: new insights on old prognostic factors?
Marc Debled, Gaëtan MacGrogan, Isabelle de Mascarel, et al.
BMC Cancer
|
January 4, 2011
Separate and combined analysis of successive dependent outcomes after breast-conservation surgery: recurrence, metastases, second cancer and death
Virginie Rondeau, Simone Mathoulin-Pélissier, Lucie Tanneau, et al.
Critical Reviews in Oncology/Hematology
|
November 2, 2010
First-line chemotherapy for metastatic breast cancer in patients ≥75 years: a retrospective single-centre analysis
Marc Debled, Nicolas Madranges, Cécile Mertens, et al.
Breast Cancer Research and Treatment
|
August 31, 2015
High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial
Céline Callens, Marc Debled, Marc Delord, et al.
Cancer Epidemiology
|
April 25, 2019
Deprivation and mass screening: Survival of women diagnosed with breast cancer in France from 2008 to 2010
Marie Poiseuil, Gaëlle Coureau, Catherine Payet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 30, 2008
D2-40 in breast cancer: should we detect more vascular emboli?
Isabelle de Mascarel, Gaëtan MacGrogan, Marc Debled, et al.
Future Oncology (London, England)
|
April 21, 2012
Complete response to exemestane in a patient with a desmoid tumor
Marc Debled, François Le Loarer, Françoise Callonnec, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 100) with videos related to
Sort By:
Page
of 10
Bulletin Du Cancer
|
March 12, 2015
[Should knowledge of BRCA1 status impact the choice of chemotherapy in metastatic breast cancer: a review]
Océane Clergue, Natalie Jones, Nicolas Sévenet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2011
Quality of randomized controlled trials reporting in the treatment of sarcomas
Maud Toulmonde, Carine Bellera, Simone Mathoulin-Pelissier, et al.
Cancer
|
April 24, 2007
Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis
Marc Debled, Gaëtan MacGrogan, Véronique Brouste, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2007
Expression profiling in breast carcinoma: new insights on old prognostic factors?
Marc Debled, Gaëtan MacGrogan, Isabelle de Mascarel, et al.
BMC Cancer
|
January 4, 2011
Separate and combined analysis of successive dependent outcomes after breast-conservation surgery: recurrence, metastases, second cancer and death
Virginie Rondeau, Simone Mathoulin-Pélissier, Lucie Tanneau, et al.
Critical Reviews in Oncology/Hematology
|
November 2, 2010
First-line chemotherapy for metastatic breast cancer in patients ≥75 years: a retrospective single-centre analysis
Marc Debled, Nicolas Madranges, Cécile Mertens, et al.
Breast Cancer Research and Treatment
|
August 31, 2015
High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial
Céline Callens, Marc Debled, Marc Delord, et al.
Cancer Epidemiology
|
April 25, 2019
Deprivation and mass screening: Survival of women diagnosed with breast cancer in France from 2008 to 2010
Marie Poiseuil, Gaëlle Coureau, Catherine Payet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 30, 2008
D2-40 in breast cancer: should we detect more vascular emboli?
Isabelle de Mascarel, Gaëtan MacGrogan, Marc Debled, et al.
Future Oncology (London, England)
|
April 21, 2012
Complete response to exemestane in a patient with a desmoid tumor
Marc Debled, François Le Loarer, Françoise Callonnec, et al.
Page
of 10